{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T06:24:43Z","timestamp":1670999083660},"reference-count":24,"publisher":"Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v102.4490","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T11:04:25Z","timestamp":1670929465000},"page":"adv00835","source":"Crossref","is-referenced-by-count":0,"title":["Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris"],"prefix":"10.2340","volume":"102","author":[{"given":"Katharina","family":"Boch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewan A.","family":"Langan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Van Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalaf","family":"Kridin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph M.","family":"Hammers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"24377","doi-asserted-by":"crossref","unstructured":"Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet 2019; 394: 882-894.","DOI":"10.1016\/S0140-6736(19)31778-7"},{"key":"24378","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0140-6736(19)31778-7","DOI":"10.1016\/S0140-6736(19)31778-7"},{"key":"24379","doi-asserted-by":"crossref","unstructured":"Futei Y, Amagai M, Ishii K, Kuroda-Kinoshita K, Ohya K, Nishikawa T. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. J Dermatol Sci 2001; 26: 55-61.","DOI":"10.1016\/S0923-1811(00)00158-4"},{"key":"24380","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0923-1811(00)00158-4","DOI":"10.1016\/S0923-1811(00)00158-4"},{"key":"24381","doi-asserted-by":"crossref","unstructured":"Funakoshi T, Lunardon L, Ellebrecht CT, Nagler AR, O'Leary CE, Payne AS. Br J Dermatol 2012; 167: 1245-1253.","DOI":"10.1111\/j.1365-2133.2012.11144.x"},{"key":"24382","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11144.x","DOI":"10.1111\/j.1365-2133.2012.11144.x"},{"key":"24383","doi-asserted-by":"crossref","unstructured":"Kricheli D, David M, Frusic-Zlotkin M, Goldsmith D, Rabinov M, Sulkes J, et al. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. Br J Dermatol 2000; 143: 337-342.","DOI":"10.1046\/j.1365-2133.2000.03659.x"},{"key":"24384","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03659.x","DOI":"10.1046\/j.1365-2133.2000.03659.x"},{"key":"24385","doi-asserted-by":"crossref","unstructured":"Joly P, Horvath B, Patsatsi \u0391, Uzun S, Bech R, Beissert S, et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV). J Eur Acad Dermatol Venereol 2020; 34: 1900-1913.","DOI":"10.1111\/jdv.16752"},{"key":"24386","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.16752","DOI":"10.1111\/jdv.16752"},{"key":"24387","doi-asserted-by":"crossref","unstructured":"Golinski ML, Lemieux A, Maho-Vaillant M, Barray M, Drouot L, Schapman D, et al. The diversity of serum anti-DSG3 IgG subclasses has a major impact on pemphigus activity and is predictive of relapses after treatment with rituximab. Front Immunol 2022; 13: 849790.","DOI":"10.3389\/fimmu.2022.849790"},{"key":"24388","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fimmu.2022.849790","DOI":"10.3389\/fimmu.2022.849790"},{"key":"24389","doi-asserted-by":"crossref","unstructured":"Mignard C, Maho-Vaillant M, Golinski ML, Balay\u00e9 P, Prost-Squarcioni C, Houivet E, et al. Factors associated with short-term relapse in patients with pemphigus who receive rituximab as first-line therapy: a post hoc analysis of a randomized clinical trial. JAMA Dermatol 2020; 156: 545-552.","DOI":"10.1001\/jamadermatol.2020.0290"},{"key":"24390","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.0290","DOI":"10.1001\/jamadermatol.2020.0290"},{"key":"24391","doi-asserted-by":"crossref","unstructured":"Boch K, Langan EA, Schmidt E, Zillikens D, Ludwig RJ, Bieber K, et al. Sustained CD19+CD27+ memory B cell depletion after rituximab treatment in patients with pemphigus vulgaris. Acta Derm Venereol 2022; 102: adv00679.","DOI":"10.2340\/actadv.v102.907"},{"key":"24392","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/actadv.v102.907","DOI":"10.2340\/actadv.v102.907"},{"key":"24393","doi-asserted-by":"crossref","unstructured":"Koneczny I. Update on IgG4-mediated autoimmune diseases: new insights and new family members. Autoimmun Rev 2020; 19: 102646.","DOI":"10.1016\/j.autrev.2020.102646"},{"key":"24394","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102646","DOI":"10.1016\/j.autrev.2020.102646"},{"key":"24395","doi-asserted-by":"crossref","unstructured":"Dalakas MC. Autoimmune neurological disorders with IgG4 antibodies: a distinct disease spectrum with unique IgG4 functions responding to anti-B Cell therapies. Neurotherapeutics 2022; 19: 741-752.","DOI":"10.1007\/s13311-022-01210-1"},{"key":"24396","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s13311-022-01210-1","DOI":"10.1007\/s13311-022-01210-1"},{"key":"24397","doi-asserted-by":"crossref","unstructured":"Goebeler M, Bata-Cs\u00f6rg\u0151 Z, De Simone C, Didona B, Remenyik E, Reznichenko N, et al. Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial. Br J Dermatol 2022; 186: 429-439.","DOI":"10.1111\/bjd.20782"},{"key":"24398","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.20782","DOI":"10.1111\/bjd.20782"},{"key":"24399","doi-asserted-by":"crossref","unstructured":"Tavakolpour S, Mahmoudi H, Mirzazadeh A, Balighi K, Darabi-Monadi S, Hatami S, et al. Pathogenic and protective roles of cytokines in pemphigus: a systematic review. Cytokine 2020; 129: 155026.","DOI":"10.1016\/j.cyto.2020.155026"},{"key":"24400","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155026","DOI":"10.1016\/j.cyto.2020.155026"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/4490\/8979","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/4490\/8980","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/4490\/8979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T11:04:41Z","timestamp":1670929481000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/4490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":24,"URL":"https:\/\/doi.org\/10.2340\/actadv.v102.4490","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,13]]}}}